Private Capital Group, LLC Sorrento Therapeutics, Inc. Transaction History

Private Capital Group, LLC

  • $133 Million
  • Q2 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 07, 2020
SELL
$1.57 - $4.76 $73 - $223
-47 Closed
0 $0
Q3 2019

Nov 13, 2019
BUY
$2.05 - $2.69 $96 - $126
47 New
47 $0
Q2 2019

Aug 15, 2019
SELL
$2.67 - $4.38 $125 - $205
-47 Closed
0 $0
Q4 2018

Jan 28, 2019
BUY
$2.01 - $4.24 $94 - $199
47 New
47 $0

Others Institutions Holding SRNE

# of Institutions
13
Shares Held
5.48M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Private Capital Group, LLC Portfolio

Follow Private Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Capital Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email